Trevi Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 08/14/2026 | 13.22 M | $246.59 M | 0.00% | 8.44% |
| FMR LLC | 08/13/2026 | 12.56 M | $234.30 M | 56.29% | 8.02% |
| BLACKROCK, INC. | 08/07/2026 | 11.16 M | $208.04 M | 8.93% | 7.12% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 9.94 M | $185.37 M | 0.00% | 6.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 5.68 M | $106.02 M | 9.55% | 3.63% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.53 M | $103.15 M | 11.09% | 3.53% |
| VIVO CAPITAL, LLC | 08/14/2026 | 5.09 M | $95.02 M | 0.00% | 3.25% |
| WOODLINE PARTNERS LP | 08/14/2026 | 4.08 M | $76.12 M | 307.81% | 2.61% |
| STATE STREET CORP | 09/22/2026 | 3.03 M | $56.46 M | 13.58% | 2.08% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 3.10 M | $57.82 M | 43.09% | 1.98% |
| MPM BIOIMPACT LLC | 08/14/2026 | 3.07 M | $57.32 M | -6.82% | 1.96% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 08/14/2026 | 3.07 M | $57.27 M | 53.98% | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.93 M | $54.62 M | 5.39% | 1.87% |
| MARSHALL WACE, LLP | 08/13/2026 | 2.67 M | $49.87 M | -32.57% | 1.71% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 2.66 M | $49.61 M | 1.44% | 1.70% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2026 | 2.50 M | $46.71 M | -32.54% | 1.60% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 2.36 M | $28.10 M | -17.22% | 1.50% |
| ARTIA GLOBAL PARTNERS LP | 08/14/2026 | 2.21 M | $41.23 M | 9.80% | 1.41% |
| ACORN CAPITAL ADVISORS, LLC | 08/14/2026 | 2.14 M | $40.00 M | 0.00% | 1.37% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2026 | 2.10 M | $39.11 M | 100.00% | 1.34% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 2.01 M | $37.56 M | 18.04% | 1.29% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 1.88 M | $35.06 M | -21.67% | 1.20% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 1.80 M | $33.57 M | -10.00% | 1.15% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 1.80 M | $33.53 M | -2.28% | 1.15% |
| SIREN, L.L.C. | 08/13/2026 | 1.79 M | $33.33 M | 0.00% | 1.14% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 1.74 M | $32.50 M | 12.16% | 1.11% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 1.61 M | $30.04 M | -4.58% | 1.03% |
| VIKING GLOBAL INVESTORS LP | 08/14/2026 | 1.54 M | $28.81 M | -51.71% | 0.99% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.53 M | $28.59 M | 25.96% | 0.98% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 1.53 M | $28.45 M | 100.00% | 0.97% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 1.43 M | $26.67 M | -41.73% | 0.91% |
| JONES HILL CAPITAL LP | 08/13/2026 | 1.34 M | $24.98 M | 261.78% | 0.86% |
| NAN FUNG TRINITY (HK) LTD | 07/24/2026 | 1.21 M | $22.63 M | 6.18% | 0.78% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/05/2026 | 1.21 M | $22.58 M | -4.08% | 0.77% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.20 M | $22.43 M | -2.06% | 0.77% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.19 M | $22.19 M | 100.00% | 0.76% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.18 M | $22.00 M | -27.18% | 0.75% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.18 M | $21.95 M | 21.50% | 0.75% |
| BARCLAYS PLC | 08/14/2026 | 1.14 M | $21.30 M | 2,031.34% | 0.73% |
| SATURN V CAPITAL MANAGEMENT LP | 08/14/2026 | 1.05 M | $19.62 M | 100.00% | 0.67% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 08/06/2026 | 1.04 M | $19.36 M | -2.37% | 0.66% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.01 M | $18.76 M | 24.72% | 0.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 972.60 K | $18.14 M | 554.95% | 0.62% |
| CANDRIAM S.C.A. | 08/13/2026 | 966.22 K | $18.00 M | 24.90% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 965.40 K | $18.00 M | 14.85% | 0.62% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 965.40 K | $18.00 M | 100.00% | 0.62% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 845.09 K | $15.76 M | 78.35% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 841.06 K | $15.69 M | 17.69% | 0.54% |
| MORGAN STANLEY | 08/13/2026 | 800.47 K | $14.93 M | 9.46% | 0.51% |
| NUVEEN, LLC | 08/11/2026 | 765.18 K | $14.27 M | 306.61% | 0.49% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trevi Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 262 institutional investors and hedge funds held shares of Trevi Therapeutics Inc. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 3.53 M
Pictet Asset Management Holding SA: 1.95 M
Candriam S.C.A.: 1.31 M
TimesSquare Capital Management, LLC: 532,097
CITIGROUP INC: 488,496
TRUST CO OF TOLEDO NA /OH/: 124,002
95.79% of Trevi Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 168.06 M shares in the last 24 months. This purchase volume represents approximately $1.97 B in transactions.